Finance

Lists
002365:SHE
Qianjiang Yongan Pharmaceutical Co Ltd
CNÂ¥14.69
-3.61%
(-0.55) 1D
Sep 3, 3:04:39 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002365...
Open
CNÂ¥15.11
High
CNÂ¥15.12
Low
CNÂ¥14.50
Mkt. cap
4.66B
Avg. vol.
37.00M
Volume
32.27M
Dividend
0.68%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 11, 2026
P/E ratio
79.64
52-wk high
CNÂ¥19.90
52-wk low
CNÂ¥9.82
EPS
CNÂ¥0.18
Shares outstanding
294.68M
No. of employees
912
Open
CNÂ¥15.11
High
CNÂ¥15.12
Low
CNÂ¥14.50
Mkt. cap
4.66B
Avg. vol.
37.00M
Volume
32.27M
Dividend
0.68%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 11, 2026
P/E ratio
79.64
52-wk high
CNÂ¥19.90
52-wk low
CNÂ¥9.82
EPS
CNÂ¥0.18
Shares outstanding
294.68M
No. of employees
912
About Qianjiang Yongan Pharmaceutical Co Ltd
CEO-
Employees912
FoundedJun 18, 2001
Headquarters-
SectorPharmaceutical industry
Websitechinataurine.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
209.77M
206.02M
235.90M
327.81M
Cost of goods sold
169.02M
173.34M
188.18M
232.78M
Cost of revenue
169.02M
173.34M
188.18M
232.78M
Research and development expenses
8.72M
4.79M
8.62M
12.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.66M
22.80M
23.64M
27.34M
Operating expense
44.57M
30.70M
37.00M
39.83M
Total operating expenses
213.59M
204.04M
225.17M
272.61M
Operating income
-3.82M
1.98M
10.73M
55.20M
Other non operating income
1.12M
-1.92M
-3.03M
-10.85M
EBT including unusual items
8.54M
-8.14M
9.16M
48.78M
EBT excluding unusual items
9.56M
5.39M
13.05M
48.30M
Income tax expense
753.52K
1.01M
1.17M
13.99M
Effective tax rate
8.82%
-12.40%
12.78%
28.67%
Other operating expenses
2.44M
2.38M
3.08M
1.95M
Net income
13.00M
-3.00M
7.74M
35.67M
Net profit margin
6.20%
-1.46%
3.28%
10.88%
Earnings per share
-
-
-
-
Interest and investment income
14.15M
5.67M
5.37M
3.96M
Interest expense
-217.73K
-203.05K
-10.40K
-
Net interest expenses
13.93M
5.47M
5.36M
3.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
24.35M
31.15M
39.90M
83.40M
Gain or loss from assets sale
32.63K
-185.68K
-
-8.23K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps